Anna Aulinas
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · IR-Sant Pau
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anna Aulinas as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:54 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07143266 · Sleep Disorders in Hypothalamic and Pituitary DamageFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · recruiting · Hypopituitarism, Sleep Wake Disorders, Hypothalamic Diseases · principal investigator
- Ph4NCT04902235 · Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · completed · Hypopituitarism, Central Diabetes Insipidus, Panhypopituitarism · principal investigator
- Ph4NCT04897802 · Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · completed · Hypopituitarism, Central Diabetes Insipidus, Panhypopituitarism · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:54 UTC. The ranking covers the 200 most relevant of 7 PubMed records, and a shared surname and initials can bring in a namesake. All 7 on PubMed
- Intranasal Oxytocin for Obesity.NEJM Evid · 202426 citationsRCR 5.1
- Sex-dependent increases in oxytocin levels in response to intravenous kisspeptin in humans.Eur J Endocrinol · 20259 citationsRCR 4.3
- 8 citationsRCR 3.7
- Melatonin as a Possible Stimulus to Unmask an Oxytocin-Deficient State in Hypopituitarism and Hypothalamic Damage.J Clin Endocrinol Metab · 20258 citationsRCR 3.5
- Arginine-Vasopressin Dynamics in Relation to Food Intake and 8-Week Intranasal Oxytocin Treatment in Adults With Obesity.J Clin Endocrinol Metab · 20252 citationsRCR 0.8
- Intravenous kisspeptin 112-121 bolus does not acutely impact circulating vasopressin in humans.J Neuroendocrinol · 2026
- Reproductive hormone stability with prolonged intranasal oxytocin in adults with obesity.Int J Obes (Lond) · 2026